714 assets in Colorectal Cancer

Therapeutic assets addressing Colorectal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pyrotinib Colorectal Cancer	Anbogen Therapeutics, Inc.	P3	B (61)
Serplulimab Colorectal Cancer	Jiangsu Cancer Institute & Hospital	P4	B (61)
Balstilimab Colorectal Cancer	National Cancer Institute (NCI)	P3	B (60)
ca102n Colorectal Cancer	Holy Stone Healthcare Co., Ltd	P2	B (60)
Dexmedetomidine Colorectal Cancer	Fudan University	P4	B (60)
Everolimus Colorectal Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	B (60)
Favezelimab Colorectal Cancer	Merck Sharp & Dohme LLC	P3	B (60)
Gm-Csf Colorectal Cancer	Brenus Pharma	P2	B (60)
Immunoglobulin G1, Anti-(Human 5'-Nucleotidase) (Human Monoclonal Medi9447 Heavy Chain), Disulfide With Human Monoclonal Medi9447 .Lambda.-Chain, Dimer Colorectal Cancer	MedImmune LLC	P2	B (60)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer Colorectal Cancer	Taiho Pharmaceutical Co., Ltd.	P3	B (60)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Cc Chemokine Receptor Ccr8) (Human-Mus Musculus Monoclonal Bms-986340 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Bms-986340 ?-Chain, Dimer Colorectal Cancer	M.D. Anderson Cancer Center	P2	B (60)
Jskn003 Colorectal Cancer	Shanghai JMT-Bio Inc.	P3	B (60)
ltc004 Colorectal Cancer	Letolab	P2	B (60)
Muamycin Colorectal Cancer	City of Hope Medical Center	P3	B (60)
Muzastotug Colorectal Cancer	City of Hope Medical Center	P2	B (60)
Nepenthe Colorectal Cancer	Local Health Unit Barcelos/Esposende, Public Health Unit	P4	B (60)
Nivestim Colorectal Cancer	Roswell Park Cancer Institute	P3	B (60)
Palbociclib Colorectal Cancer	Lebanese University	P2	B (60)
Retlirafusp Alfa Colorectal Cancer	Fudan University	P2/3	B (60)
Thymosin Alpha 1 Colorectal Cancer	Fudan University	P3	B (60)
tqb2102 Colorectal Cancer	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	P3	B (60)
Adriamycin Colorectal Cancer	Junpeng Wang	P3	B (59)
Atezolizumab Colorectal Cancer	Exelixis	P3	B (59)
Cabozantinib Colorectal Cancer	Exelixis	P3	B (59)
Cis-Diamminedichloroplatinum Ii Colorectal Cancer	Tianjin Medical University Cancer Institute and Hospital	P3	B (59)
Floxuridine Colorectal Cancer	ECOG-ACRIN Cancer Research Group	P3	B (59)
Pucotenlimab Colorectal Cancer	Sun Yat-sen University	P3	B (59)
Sotorasib Colorectal Cancer	M.D. Anderson Cancer Center	P3	B (59)
Adagrasib Colorectal Cancer	M.D. Anderson Cancer Center	P3	B (58)
Allostim® Colorectal Cancer	Mirror Biologics, Inc.	P2/3	B (58)
Avutometinib Colorectal Cancer	M.D. Anderson Cancer Center	P2	B (58)
Binimetinib Colorectal Cancer	Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)	P2	B (58)
Carboplatin Colorectal Cancer	Revolution Medicines, Inc.	P3	B (58)
Docetaxel Colorectal Cancer	NuCana plc	P2	B (58)
Huaier Granule Colorectal Cancer	Fudan University	P4	B (58)
Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer Colorectal Cancer	Chinese PLA General Hospital	P3	B (58)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Colorectal Cancer	Vall d'Hebron Institute of Oncology	P2	B (58)
Neomycin Colorectal Cancer	M.D. Anderson Cancer Center	P4	B (58)
ngm707 Colorectal Cancer	NGM Biopharmaceuticals, Inc	P2	B (58)
Olaparib Colorectal Cancer	Grupo Espanol Multidisciplinario del Cancer Digestivo	P3	B (58)
Polo-Like Kinase 1 Inhibitor Nms-1286937 Colorectal Cancer	Cardiff Oncology	P2	B (58)
Relatlimab Colorectal Cancer	Exelixis	P2	B (58)
Ruxolitinib Colorectal Cancer	Philogen S.p.A.	P2	B (58)
Surufatinib Colorectal Cancer	Fujian Cancer Hospital	P2	B (58)
Telisotuzumab Adizutecan Colorectal Cancer	AbbVie	P3	B (58)
Trastuzumab Deruxtecan Colorectal Cancer	M.D. Anderson Cancer Center	P2	B (58)
Tuvonralimab Colorectal Cancer	Jiangsu Cancer Institute & Hospital	P2	B (58)
Vandazole Colorectal Cancer	Virginia Commonwealth University	P4	B (58)
Dabrafenib Colorectal Cancer	Tianjin Medical University Cancer Institute and Hospital	P2	B (57)
Famitinib Colorectal Cancer	Huazhong University of Science and Technology	P3	B (57)

Showing 51 to 100 of 714 assets

PreviousPage 2 of 15Next